Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
700.33
+4.31 (0.62%)
Feb 21, 2025, 4:00 PM EST - Market closed
Regeneron Pharmaceuticals Revenue by Segment
History
| Date | Net Product | Collaboration | Other |
|---|---|---|---|
| Dec 31, 2024 | 7.63B | 6.06B | 515.00M |
| Sep 30, 2024 | 7.48B | 5.82B | 548.10M |
| Jun 30, 2024 | 7.32B | 5.60B | 572.20M |
| Mar 31, 2024 | 7.17B | 5.39B | 537.00M |
| Dec 31, 2023 | 7.08B | 5.50B | 536.10M |
| Sep 30, 2023 | 6.93B | 5.72B | 451.30M |
| Jun 30, 2023 | 6.94B | 5.33B | 397.20M |
| Mar 31, 2023 | 6.92B | 5.06B | 387.10M |
| Dec 31, 2022 | 6.89B | 4.91B | 365.10M |
| Sep 30, 2022 | 9.17B | 4.22B | 323.60M |
| Jun 30, 2022 | 9.65B | 4.24B | 338.40M |
| Mar 31, 2022 | 12.03B | 4.15B | 325.20M |
| Dec 31, 2021 | 12.12B | 3.67B | 281.20M |
| Sep 30, 2021 | 9.76B | 3.46B | 318.40M |
| Jun 30, 2021 | 8.97B | 3.04B | 378.00M |
| Mar 31, 2021 | 6.06B | 2.60B | 543.80M |
| Dec 31, 2020 | 5.57B | 2.37B | 557.00M |
| Sep 30, 2020 | 5.23B | 2.18B | 529.10M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.